Nurix Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Nurix Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Nurix Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Nurix Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $240k | 23k | 10.32 |
| 2023-09-30 | $183k | 23k | 7.86 |
| 2023-06-30 | $233k | 23k | 9.99 |
| 2023-03-31 | $207k | 23k | 8.88 |
| 2022-12-31 | $256k | 23k | 10.98 |
| 2022-09-30 | $303k | 23k | 13.03 |
| 2022-06-30 | $295k | 23k | 12.67 |
| 2022-03-31 | $262k | 19k | 14.01 |
| 2021-12-31 | $341k | 12k | 28.95 |
| 2021-09-30 | $353k | 12k | 29.97 |
| 2021-06-30 | $313k | 12k | 26.53 |
| 2021-03-31 | $296k | 9.5k | 31.09 |
| 2020-12-31 | $167k | 5.1k | 32.88 |
| 2020-09-30 | $178k | 5.1k | 34.98 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors